🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHypoglycemia risk with concomitant sulfonylurea use Page 2

Hypoglycemia risk with concomitant sulfonylurea use

SarahChen_PharmD Thu, Jun 4, 2026 at 1:39 AM 6 replies 271 viewsPage 2 of 2
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jun 4, 2026 at 5:19 AM#6

Adding the numbers, since they settle part of this. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

That is the short version; the long version is somebody else's post.

4 24VendorMark, COA_Karl, MikeFit_NJ and 1 other
Reply Quote Save Share Report
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Jun 4, 2026 at 6:45 AM#7

A narrower follow-up, since the general answer is now clear:

What distinguishes the nausea you can titrate through from the nausea that means stop?

3 23FranDenver, Dr.BariatricHTX, LindaRN_retired
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Jun 4, 2026 at 8:11 AM#8
DataDave said:
One practical note: write down what you did and when, before you need it.

There is a second half to this that has not been said yet. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

2 22AussieAnna, BethLabQueen
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Jun 4, 2026 at 9:37 AM#9

OP back with an update, since a thread like this is useless without one.

Holding the step for six weeks instead of four did it. Same dose, same food, and the nausea that had felt like a wall turned out to be a timing problem.

1 21TinaHashiRN
Reply Quote Save Share Report
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Jun 4, 2026 at 4:28 PM#10
anders_CPH said:
It helps to say which part of this you are uncertain about.

No disagreement with anders_CPH. One condition attached. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Last edited: Jun 4, 2026 at 5:28 PM
25 23nancy_portland, rick_sfbay, maria_elpaso and 22 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register